Barriers to antibiotic lock therapy in children with intravascular catheter-related bloodstream infections [4]

Pediatric Infectious Disease Journal

Volumn 24, Issue 10, 2005, Pages 944-

  Robinson, Joan L ^a   Tawfik, Gerda ^a   Roth, Ann ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; HEPARIN; PLACEBO; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; INTRAVASCULAR CATHETER; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURVIVAL TIME;

EID: 26944447080     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000181547.71123.c8     Document Type: Letter

References (4)

1. Segarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: a review of the literature. Ann Pharmacother. 2005;39:311-318.
2. De Sio L, Jenkner A, Milano GM, et al. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. Pediatr Infect Dis J. 2004;23:963-965.
3. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
4. Rijinders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteremia with antibiotic lock: randomized, placebo-controlled trail. J Antimicrob Chemother. 2005; 55:90-94.